MHRA authorization to initiate Phase 1/2 clinical trial at U.K. sites follows first U.S. patient dosing with EN-374 for treatment of X-linked chronic granulomatous disease BOSTON, December 10, ...

PHILADELPHIA, Nov. 24, 2025 /PRNewswire/ -- Gemma Biotherapeutics ("GEMMABio"), a leading global genetic medicines company, announced that its novel gene therapy for spinal muscular atrophy type 1 ...

Payment card handlers and processors complete the Payment Card Authorization Form when a customer is not able to self-enter a payment card transaction. The Payment Card Authorization Form is completed ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Therapists treating Medicaid enrollees in Colorado will have to get the state’s authorization to conduct more than 24 sessions with an individual patient in a year, as the department overseeing the ...

Aiman says these artworks are not meant to scare; rather they are personal reflections of his innermost thoughts and emotions. (Bernama pic) At first glance, the paintings of 29-year-old artist Aiman ...

A new study led by Mass General Brigham investigators compared the effects of repeated intravenous (IV) ketamine and intranasal (IN) esketamine in patients with treatment-resistant depression. In a ...

Gilead Sciences (NASDAQ:GILD) announced on Tuesday that the European Commission granted marketing authorization for its antiviral therapy lenacapavir as a twice-yearly option for the prevention of HIV ...

Humana is offering a voluntary early retirement program to eligible employees at least 50 years old with at least three years of service. The company cites "evaluating staffing needs" as the reason ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the latest insurer to address the tedious paperwork process that has been a pain ...

Invivyd's SPEAR Study Group will investigate PEMGARDA®'s efficacy in treating Long COVID and Post-Vaccination Syndrome through monoclonal antibody therapy. Invivyd, Inc. has established the SPEAR ...